Literature DB >> 23891349

Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.

Shoshana Revel-Vilk1, Joanne Yacobovich, Shlomzion Frank, Tal Ben-Ami, Michal Yechieli, Vered Shkalim, Asaf Lebel, Rotem Semo-Oz, Hannah Tamary.   

Abstract

OBJECTIVE: To evaluate the predictive value of clinical features at diagnosis of immune thrombocytopenia (ITP) for resolution of disease. STUDY
DESIGN: Hospital records of 472 consecutive children (<18 years old) with ITP cared for at 2 participating centers were reviewed retrospectively and data related to the initial presentation were recorded. Logistic regression analysis was used for calculating prediction of resolution at 3, 6, and 12 months from diagnosis.
RESULTS: The most significant predictors for resolution of ITP at 3, 6, and 12 months were age at onset <10 years and abrupt onset (history of <2 weeks of bleeding). We designed a prediction rule for ITP chronicity based on these criteria. The rate of developing chronic ITP for low, intermediate, and high risk children at diagnosis of ITP was 11%, 39%, and 63%, respectively. Recovery rate at 3 months for low, intermediate, and high risk children was 72%, 43% and 30%, respectively.
CONCLUSIONS: We present a simple rule to predict recovery from ITP at 3, 6, and 12 months from diagnosis. For prediction of resolution at 3 months, our rule was in agreement with the more complex, previously described Nordic score. Prediction of resolution of ITP may enable practitioners to better inform children and parents at the time of diagnosis, resulting in reduced anxiety and improved quality of life.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  IGIV; ITP; Immune thrombocytopenia; immunoglobulin intravenous

Mesh:

Substances:

Year:  2013        PMID: 23891349     DOI: 10.1016/j.jpeds.2013.06.018

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

Review 2.  The Use of Clinical Scores in the Management of Immune Thrombocytopenic Purpura in Children.

Authors:  Vasile Eduard Roşu; Elena-Lia Spoială; Tamara Solange Roşu; Anca-Viorica Ivanov; Adriana Mocanu; Alecsandra Munteanu; Vasile Valeriu Lupu; Ingrith Miron; Cristina Gavrilovici
Journal:  Front Pediatr       Date:  2022-05-09       Impact factor: 3.569

3.  Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study.

Authors:  Emilia Parodi; Giovanna Russo; Piero Farruggia; Lucia D Notarangelo; Maria T Giraudo; Margherita Nardi; Fiorina Giona; Paola Giordano; Ugo Ramenghi; Angelica Barone; Gianluca Boscarol; Simone Cesaro; Francesca Fioredda; Saverio Ladogana; Maria Licciardello; Francesca Rossi; Laura Rubert; Marco Spinelli; Fabio Tucci
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

4.  Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis.

Authors:  Alexandros Makis; Athanasios Gkoutsias; Theodoros Palianopoulos; Eleni Pappa; Evangelia Papapetrou; Christina Tsaousi; Eleftheria Hatzimichael; Nikolaos Chaliasos
Journal:  Adv Hematol       Date:  2017-12-06

5.  Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.

Authors:  Michael D Tarantino; James B Bussel; Victor S Blanchette; Donald Beam; John Roy; Jenny Despotovic; Ashok Raj; Nancy Carpenter; Bhakti Mehta; Melissa Eisen
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

6.  Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.

Authors:  Tao Li; Gui-Ling Yan; Zhu Luo; Qi Xie; Mei-Mei Lai; Zhan-Guo Chen; Xiao-Qun Zheng
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

7.  Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.

Authors:  Hyoung Soo Choi; Mi Hong Ji; Sung Jin Kim; Hyo Seop Ahn
Journal:  Blood Res       Date:  2016-06-23

8.  A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.

Authors:  David E Schmidt; Pernille Wendtland Edslev; Katja M J Heitink-Pollé; Bart Mertens; Marrie C A Bruin; Rick Kapur; Gestur Vidarsson; C Ellen van der Schoot; Leendert Porcelijn; Johanna G van der Bom; Steen Rosthøj; Masja de Haas
Journal:  J Thromb Haemost       Date:  2020-11-27       Impact factor: 5.824

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.